/206A.T
206A.T Stock - PRISM BioLab Co.,LTD
Healthcare|BiotechnologyJPX
$148.00-3.27%
$5.00 (-3.27%) • Dec 24
55
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.1
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.100
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $162.80
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for 206A.T
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$146.52 – $149.48
TARGET (TP)$170.20
STOP LOSS$136.16
RISK/REWARD1:1.9
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta-0.54
52W High$330.00
52W Low$132.00
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Revenue | $677.33M | $305.62M | $112.93M | $554.40M |
| Gross Profit | $269.76M | $160.54M | $80.31M | $535.14M |
| Gross Margin | 39.8% | 52.5% | 71.1% | 96.5% |
| Operating Income | $-774,452,000 | $-782,392,000 | $-496,868,000 | $66.68M |
| Net Income | $-833,700,000 | $-1,049,514,000 | $-526,914,000 | $72.96M |
| Net Margin | -123.1% | -343.4% | -466.6% | 13.2% |
| EPS | $-22.82 | $-33.53 | $-14.90 | $2.06 |
Company Overview
PRISM Pharma Co., Ltd. operates as a pharmaceutical company that focuses on discovery and development of small molecules to modulate protein-protein interactions. It utilizes protein secondary structure mimetic library, which modulates intracellular protein and protein interactions. The firm develops an anti-cancer drug CP/Catenin inhibitor PRI-724 that acts on both cancer cells and cancer stem cells that can switch from proliferation to differentiation. The company was founded by Hiroyuki Kouji on November 2, 2006 and is headquartered in Fujisawa, Japan.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
206A.TBeat Rate
0%
Last 0 quarters
Avg Surprise
+0%
EPS vs Estimate
Beats / Misses
0/0
Last 12 quarters
Latest EPS
$-0.81
Q4 2025
EPS Surprise History
Q2 24
No data
Q4 24
No data
Q1 25
No data
Q2 25
No data
Q4 25
No data
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q4 2025 | Nov 14, 2025 | — | $-0.81 | — | — |
Q3 2025 | Aug 14, 2025 | — | — | — | — |
Q2 2025 | May 14, 2025 | — | $-7.75 | — | — |
Q1 2025 | Feb 14, 2025 | — | $-5.30 | — | — |
Q4 2024 | Nov 15, 2024 | — | $-13.42 | — | — |
Q3 2024 | Aug 14, 2024 | — | — | — | — |
Q2 2024 | Jun 29, 2024 | — | $-7.45 | — | — |
Latest News
Loading news...
Frequently Asked Questions about 206A.T
What is 206A.T's current stock price?
PRISM BioLab Co.,LTD (206A.T) is currently trading at $148.00 per share. The stock has moved -3.27% today.
What is the analyst price target for 206A.T?
No analyst price targets are currently available for this stock.
What sector is PRISM BioLab Co.,LTD in?
PRISM BioLab Co.,LTD operates in the Healthcare sector, specifically within the Biotechnology industry. The company is traded on the JPX exchange.
What is 206A.T's market cap?
PRISM BioLab Co.,LTD has a market capitalization of $5.45 billion, making it a mid-cap company.
Does 206A.T pay dividends?
No, PRISM BioLab Co.,LTD does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare Sector2385.T
Soiken Holdings Inc.
$238.00
Mkt Cap: $6.2B
4572.T
Carna Biosciences, Inc.
$415.00
Mkt Cap: $7.9B
4576.T
D. Western Therapeutics Institute, Inc.
$93.00
Mkt Cap: $4.1B
4591.T
Ribomic Inc.
$74.00
Mkt Cap: $3.5B
4594.T
BrightPath Biotherapeutics Co., Ltd.
$46.00
Mkt Cap: $4.3B
4598.T
Delta-Fly Pharma, Inc.
$500.00
Mkt Cap: $5.7B
4883.T
Modalis Therapeutics Corporation
$55.00
Mkt Cap: $4.2B
4891.T
TMS Co., Ltd.
$127.00
Mkt Cap: $5.8B
4892.T
Cyfuse Biomedical K.K.
$588.00
Mkt Cap: $5.2B
4893.T
Noile-Immune Biotech Inc.
$133.00
Mkt Cap: $5.8B
Explore stocks similar to 206A.T for comparison